Swedbank Ab Liva Nova PLC Transaction History

Swedbank Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 09, 2024	SELL	$57.25 - $86.63 $22.9 Million - $34.7 Million	-400,000 Closed	0 $0
Q1 2022 Dec 09, 2024	BUY	$71.02 - $86.99 $1.78 Million - $2.17 Million	25,000 Added 6.67%	400,000 $32.7 Million
Q4 2021 Dec 09, 2024	SELL	$76.72 - $92.68 $2.3 Million - $2.78 Million	-30,000 Reduced 7.41%	375,000 $32.8 Million
Q2 2021 Dec 09, 2024	SELL	$73.44 - $87.01 $3.3 Million - $3.92 Million	-45,000 Reduced 10.0%	405,000 $34.1 Million
Q1 2021 Dec 09, 2024	BUY	$62.9 - $82.41 $28.3 Million - $37.1 Million	450,000 New	450,000 $33.2 Million

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.